Research > Cancer

Oncological pathology

Number of publications
574
Publications search

  • Giavedoni, P; Romaní, J; de Cabo, F; García-Martínez, FJ; Quintana-Codina, M; Roè-Crespo, E; de Vega, IF; Soria-Gili, X; Aguayo-Ortiz, R; Garbayo-Salmons, P; Castillo, G; Vidal-Sarró, D; Mollet, J; Serra, L; Gonzalez, C; López-Trujillo, E; Just, M; Combalia, M; Podlipnik, S; Malvehy, J; Wortsman, X

    Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin

    Diagnostics 15 -. .

    [doi:10.3390/diagnostics15050569]

  • Maiques, O; Sallan, MC; Laddach, R; Pandya, P; Varela, A; Crosas-Molist, E; Barcelo, J; Courbot, O; Liu, YB; Graziani, V; Arafat, Y; Sewell, J; Rodriguez-Hernandez, I; Fanshawe, B; Jung-Garcia, Y; Imbert, PRC; Grasset, EM; Albrengues, J; Santacana, M; Macià, A; Tarragona, J; Matias-Guiu, X; Marti, RM; Tsoka, S; Gaggioli, C; Orgaz, JL; Fruhwirth, GO; Wallberg, F; Betteridge, K; Reyes-Aldasoro, CC; Haider, S; Braun, A; Karagiannis, SN; Elosegui-Artola, A; Sanz-Moreno, V

    Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis

    Nature Communications 16 1394-1394. .

    [doi:10.1038/s41467-025-56299-7]

  • Rodríguez-Martínez, A; Torrejón-Escribano, B; Eritja, N; Dorca-Arévalo, J; Gabaldón, C; Sévigny, J; Matias-Guiu, X; Martín-Satué, M

    Endometrial epithelial cell organoids as tools for studying the CD39 family of enzymes and for validating enzyme inhibitors

    HISTOLOGY AND HISTOPATHOLOGY 40 171-182. .

    [doi:10.14670/HH-18-782]

  • Quesada, S; Penault-Llorca, F; Matias-Guiu, X; Banerjee, S; Barberis, M; Coleman, RL; Colombo, N; Defazio, A; Mcneish, IA; Nogueira-Rodrigues, A; Oaknin, A; Pignata, S; Pujade-Lauraine, É; Rouleau, E; Ryska, A; van der Merwe, N; Van Gorp, T; Vergote, I; Weichert, W; Wu, XH; Ray-Coquard, I; Pujol, P

    Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics

    EUROPEAN JOURNAL OF CANCER 215 115169-115169. .

    [doi:10.1016/j.ejca.2024.115169]

  • Vredea, SW; Van Weelden, WJ; Bulten, J; Gilks, CB; Teerenstra, S; Huvila, J; Matias-Guiu, X; Gil-Moreno, A; Asbergerj, J; Sweegers, S; van der Putten, LJM; Kuesters-Vandevelde, HVN; Reijnen, C; Colasi, E; Hausnerova, J; Weinberger, V; Snijders, MPLM; Vinklerova, P; Ravaggi, A; Odicino, F; Bignotti, E; Mcalpine, JN; Kruitwagen, R; Pijnenborga, JMA

    Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer

    GYNECOLOGIC ONCOLOGY 192 15-23. .

    [doi:10.1016/j.ygyno.2024.10.028]

  • González Rodríguez J.; Jatem Escalante E.; Buil Campo J.C.; Pinyol Ribas M.; Martín Conde M.L.

    Late-Onset Lupus Nephritis: Clinical-Epidemiological, Histological, Prognostic, and Therapeutic Implications: A Single-Center Experience from Northeastern Spain

    Glomerular Diseases 109-118. .

    [doi:10.1159/000543706]

  • Matias-Guiu, X; Raspollini, MR; Kulka, J; Ryska, A; Dieri, RA; Schirmacher, P; European Society of Pathology ESP

    The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of Pathology

    VIRCHOWS ARCHIV 486 207-214. .

    [doi:10.1007/s00428-024-04005-1]

  • Alberti-Valls, M; Olave, S; Olomí, A; Macià, A; Eritja, N

    Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment

    Cancers 16 -. .

    [doi:10.3390/cancers16233918]

  • Matias-Guiu, X; Lax, S; Raspollini, MR; Palacios, J; Zheng, WX; Liu, CR; de Brot, L; Lordello, L; Hardisson, D; Gaffney, D; Mutch, D; Scambia, G; Creutzberg, CL; Fotopoulou, C; Berek, JS; Concin, N

    FIGO 2023 staging for endometrial cancer, when, if it is not now?

    EUROPEAN JOURNAL OF CANCER 213 115115-115115. .

    [doi:10.1016/j.ejca.2024.115115]

  • Moreno-Moreno, E; Caniego-Casas, T; Carretero-Barrio, I; Cortés, A; Muriel, A; Domínguez-Rullán, JA; Martín-Gromaz, C; Moreno-Bueno, G; Matías-Guiu, X; Palacios, J; Pérez-Mies, B

    Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 48 1580-1587. .

    [doi:10.1097/PAS.0000000000002308]

  • Morice, P; Scambia, G; Abu-Rustum, NR; Acien, M; Arena, A; Brucker, S; Cheong, Y; Collinet, P; Fanfani, F; Filippi, F; Eriksson, AGZ; Gouy, S; Harter, P; Matias-Guiu, X; Pados, G; Pakiz, M; Querleu, D; Rodolakis, A; Rousset-Jablonski, C; Stepanyan, A; Testa, AC; Macklon, KT; Tsolakidis, D; De Vos, M; Planchamp, F; Grynberg, M

    Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

    LANCET ONCOLOGY 25 602-610. .

    [doi:10.1016/S1470-2045(24)00262-6]

  • Iznardo, H; Roé, E; Vicente, A; Prat, C; Casals, M; Martín-Santiago, A; Esteve, A; Viñas, M; Munera-Campos, M; Corella, F; Mollet, J; Figueras-Nart, I; Vila, A; Soria, X; Azón-Masoliver, A; Marqués-Martín, L; Nadal-Lladó, C; Bel, S; Pujol-Montcusí, J; Bertolín-Colilla, M; Curto-Barredo, L; Melé-Ninot, G; Evole, M; Berbegal, L; Puig, L; Baselga, E

    Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 50 104-112. .

    [doi:10.1093/ced/llae300]